Escitalopram in Schizophrenia in OCD- Open Label Study

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: BeerYaakov Mental Health Center
• Collaborator: Lundbeck Israel
• Treatments: Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• Patients who suffer from schizophrenia and OCD

Exclusion Criteria:

• Substance abuse,

• Serious medical condintions,

• Being on SSRI treatment